"Significant Immunological Outcomes in BIT225 HIV-1 Clinical Trial "
Can someone explain how they came to this conclusion in a short time frame after treatment based on 27 patients with half on placebo. The variability of data on such a small patient population looking at immune system ages and neurocognitive disorder is going to give you non conclusive data imo. Longer term data on over 300 patients in a phase 2b study can only give any significant results. IMO the reported results are a beat up to get the 6c options exercised.
"These include an immune system ages more quickly, and there are other problems such as HIV-associated neurocognitive disorder (also known as AIDS-related dementia).
- Forums
- ASX - By Stock
- BIT
- $10 Billion Deal
$10 Billion Deal, page-141
-
- There are more pages in this discussion • 13,127 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.77M |
Open | High | Low | Value | Volume |
3.4¢ | 3.4¢ | 3.3¢ | $26.66K | 804.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 296338 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 76443 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 296338 | 0.033 |
5 | 457406 | 0.032 |
3 | 350500 | 0.031 |
9 | 670666 | 0.030 |
2 | 250000 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 76443 | 2 |
0.036 | 65500 | 1 |
0.037 | 537816 | 2 |
0.039 | 490546 | 3 |
0.040 | 113240 | 2 |
Last trade - 15.00pm 18/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |